NCT00478829

Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in China

Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in 5 Large Cities in China

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 8,000 (planned)
• Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Objectives: Primary: To estimate the prevalence of depression and/or anxiety disorder in outpatients attending the general health care settings in China. Secondary: * To estimate gender- and age-specific prevalence of depression and/or anxiety disorder in outpatients attending the general health care settings in China. * To estimate the prevalence of depression and/or anxiety disorder in outpatients attending the general health care settings such as departments of neurology, gastroenterology, cardiology, and gynecology. * To describe the recognition and treatment rate by treating physicians as depression and/or anxiety for outpatients in the general health care settings in China.

Detailed description

This study is designed to investigate the status of identifying depression and/or anxiety disorder with somatic symptoms in general hospitals in China. The study will generate valuable information to the medical community; therefore the early and vigorous treatment is possible. It's in line with China government authorities' target to increase the recognition rate of depression and/or anxiety in primary care settings to more than 50% by the end of 2010. The study will also help to identify specific diagnosis and treatment patterns for depressive / anxious patients and their comorbid conditions.

Conditions

• Adult

Timeline

• Start date: 2007-04-01
• Completion: 2007-07-01
• First posted: 2007-05-25
• Last updated: 2007-12-06

Locations

15 sites across 1 country: China